Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

92 - Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB.
Intavesical botulinum toxin A administration produces analgesia against acetic acid
induced bladder pain responses in rats.
J Urol 2004; 172 : 1529-32.
93 - Rapp DE, Turk KW, Bales GT, Cook SP.
Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated
rat bladder.
J Urol 2006 ; 175 : 1138-42.
94 - Welch MJ, Purkiss JR, Foster KA.
Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum
neurotoxins.
Toxicon 2000 ; 38 : 245-58
95 - Blersch W, Schulte-Mattler WJ, Przywara S, May A, Bigalke H, Wohlfarth K.
Botulinum toxin A and the cutaneous nociception in humans : a prospective,
double-blind, placebo-controlled, randomized study.
J Neurol Sci 2002 ; 205 : 59-63.
96 - Krämer HH, Angerer C, Erbguth F, Schmelz M, Birklein F.
Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and
hyperalgesia in human skin.
J Neurol 2003 ; 250 : 188-93.
97 - A. QARRO, Y. EL HARRECH, J. CHAFIKI, F. HAJJI, T. OULD ISMAIL, J. SOSSA,
A. JANANE, A. AMEUR, M. ABBAR
TOXINE BOTULINIQUE A : ALTERNATIVE AU TRAITEMENT DE L’HYPERTROPHIE
BENIGNE DE LA PROSTATE
J Maroc Urol 2010 ; 18 : 27-32
98 - DOGGWEILER R., ZERMANN D.H., ISHIGOOKA M., SCHMIDT R.A.:
Botox-induced prostatic involution.
Prostate, 1998 ; 37 : 44-50.
99 - Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A
Relief by botulinumtoxin of voiding dysfunction due to benign prostatic hyperplasia:
results of a randomized, placebo-controlled study.
Urology. (2003 Aug) 62(2): 259-64
100